The Competition Commission of India (CCI) has dismissed a case of alleged cartelisation by Romsons Scientific & Surgical Industrial Pvt Ltd and BSN Medical Pvt Ltd and some of their officials.
The regulator had directed the director general (DG) to carry out an investigation after the matter originated from a complaint alleging cartelisation by the firms in respect of a tender invited by AIIMS in 2016.
The DG after taking into consideration the submissions of the parties, concluded that different parties, at different geographical locations with different cost of production and profit margins quoting identical rates, independently, would be too much of coincidence, which is difficult to believe.
Accordingly, the DG concluded that the firms colluded and acted in contravention of provisions of the Competition Act.
However, the CCI said that there is no evidence of any communications or meetings having taken place between the opposite parties (OPs) or any other arrangement indicating a tacit collusion in respect of fixing the prices for the bids.
Apart from the present instance of identical pricing during the period under consideration, the investigation report falls short of providing clarity as to how such pricing was an outcome of collusion.
"There is lack of material to show any collusion on part of the OPs and the Commission, thus, concludes that it is not established that OP-1 and OP-2 have acted in contravention of the provisions of ...of the Act," the regulator said.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)